ConductScience.org, home

Paper37870

Improved physical performance as a therapeutic objective in patients with angina.

Ling AS and 1 other. Br J Clin Pharmacol, 1979. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Improved physical performance as a therapeutic objective in patients with angina. Papers, record 37870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37870

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Improved physical performance as a therapeutic objective in patients with angina.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ling ASA S
2Groel JTJ T

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
Angina PectorisMajor topic
PropanolaminesMajor topic
PropranololMajor topic
Adult
Aged
Drug Evaluation
Female
Humans
Male
Middle Aged
Work Capacity Evaluation

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,562Treatment of angina pectoris. Pharmacologic approaches.Postgrad Med1976https://conductscience.org/library/papers/10562PubMed
210,600The clinical pharmacology of beta-adrenoceptor-blocking drugs.Prog Cardiovasc Dis1976https://conductscience.org/library/papers/10600PubMed
31,094,291Drug therapy: Propranolol.N Engl J Med1975https://conductscience.org/library/papers/1094291PubMed
41,256,530Hypertension and compliance: implications for the primary physician.N Engl J Med1976https://conductscience.org/library/papers/1256530PubMed
513,887,414Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide).Lancet1962https://conductscience.org/library/papers/13887414PubMed
614,132,613A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.Lancet1964https://conductscience.org/library/papers/14132613PubMed
716,040Metabolic studies in patients with nadolol: oral and intravenous administration.J Clin Pharmacol1977https://conductscience.org/library/papers/16040PubMed
8191,753Myocardial ischemia (first of three parts).N Engl J Med1977https://conductscience.org/library/papers/191753PubMed
9241,655Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.Eur J Pharmacol1975https://conductscience.org/library/papers/241655PubMed
10406,767The management of the patient with angina.Am Heart J1977https://conductscience.org/library/papers/406767PubMed
114,202,577Exercise tolerance and physical training of non-selected patients after myocardial infarction.Acta Med Scand Suppl1973https://conductscience.org/library/papers/4202577PubMed
124,397,655Comparison of adrenergic beta-blocking drugs in angina pectoris.Br Med J1971https://conductscience.org/library/papers/4397655PubMed
134,405,104Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4405104PubMed
144,635,437Some comments and reflections on changing interests and new developments in angina pectoris.Circulation1972https://conductscience.org/library/papers/4635437PubMed
155,041,658Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites.J Pharmacol Exp Ther1972https://conductscience.org/library/papers/5041658PubMed
166,243Clinical pharmacokinetics of beta-adrenoreceptors blockers.Drugs1976https://conductscience.org/library/papers/6243PubMed
17787,954Propranolol in the treatment of angina: a review.Postgrad Med J1976https://conductscience.org/library/papers/787954PubMed
18934,973Factors influencing the choice of antihypertensive agents.Postgrad Med1976https://conductscience.org/library/papers/934973PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
6,137,236Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes.Br J Ophthalmol1983https://conductscience.org/library/papers/6137236PubMed
6,105,067Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.Drugs1980https://conductscience.org/library/papers/6105067PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37870

GET https://conductscience.org/api/papers/v1/37870/authors